DOCSLIB.ORG

Targeting the Complement Cascade in the Pathophysiology of COVID-19 Disease

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Journal of Clinical Medicine Review Targeting the Complement Cascade in the Pathophysiology of COVID-19 Disease Nicole Ng and Charles A. Powell * Division of Pulmonary, Critical Care and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; [email protected] * Correspondence: [email protected] Abstract: Severe coronavirus disease 2019 causes multi-organ dysfunction with significant morbidity and mortality. Mounting evidence implicates maladaptive over-activation of innate immune path- ways such as the complement cascade as well as endothelial dysfunction as significant contributors to disease progression. We review the complement pathways, the effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on these pathways, and promising therapeutic targets in clinical trials. Keywords: COVID-19; SARS-CoV-2; complement pathway; lectin pathway; complement inhibitor; mannose-associated serine protease inhibitor 1. Introduction Severe coronavirus disease 2019 (COVID-19) is a multi-system disorder characterized by microvascular dysregulation and thrombosis that causes acute respiratory distress Citation: Ng, N.; Powell, C.A. syndrome (ARDS), kidney injury, cardiomyopathy, and encephalitis. Evidence suggests Targeting the Complement Cascade that this is driven by exuberant host responses leading to maladaptive over-activation of in the Pathophysiology of COVID-19 innate immune pathways, most notably the complement cascade. Disease. J. Clin. Med. 2021, 10, 2188. https://doi.org/10.3390/jcm10102188 2. The Complement Cascade The complement cascade is a host defense system that traces its biologic origins to over Academic Editors: Philippe Guilpain one billion years ago [1]. This system consists of more than fifty plasma proteins that inter- and Maciej Markiewski act to sense and respond to invasive pathogens [2]. It is a component of the innate immune response that links the innate and adaptive responses. Activation occurs via one of three Received: 26 March 2021 Accepted: 14 May 2021 pathways—classical, lectin, or alternative pathway, that converge to form C5 convertase, as Published: 19 May 2021 well as numerous anaphylatoxins (Figure1). C5 convertase generates C5b-9, also known as membrane attack complex (MAC). MAC creates cytotoxic membrane channels leading Publisher’s Note: MDPI stays neutral to cell death; however, even sublytic concentrations have significant immunomodulatory with regard to jurisdictional claims in effects [3]. Anaphylatoxins produce a host of proinflammatory responses that range from published maps and institutional affil- increased vascular permeability to the activation and recruitment of leukocytes [4]. iations. The important role of the complement cascade in responding to viral infections is demonstrated by evolutionary evidence of specific mechanisms employed by viruses to evade the complement system [5,6]. These include piracy of host regulators of complement activation (e.g., complement factor H by Flaviviridae), viral mimicry of host complement- related proteins (e.g., Vaccinia viridae encoding of vaccinia virus complement control protein, Copyright: © 2021 by the authors. Licensee MDPI, Basel, Switzerland. VCP), or encoding of proteins to prevent complement mediated effects (e.g., Influenza A This article is an open access article encoding of matrix, M1, protein to prevent neutralization, or Variola viridae encoding distributed under the terms and smallpox inhibitor of complement enzyme, SPICE, to inhibit C3 convertase) [6–9]. conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/). J. Clin. Med. 2021, 10, 2188. https://doi.org/10.3390/jcm10102188 https://www.mdpi.com/journal/jcm J. Clin. Med. 2021, 10, x FOR PEER REVIEW 2 of 13 J. Clin. Med. 2021, 10, 2188 2 of 13 FigureFigure 1. ComplementComplement activation activation pathways. pathways. The The classica classicall pathway pathway is activated is activated by the by binding the binding of ofantibody-antigen antibody-antigen complex complex with with the theC1 esterase C1 esterase complex complex (C1qC1rC1s), (C1qC1rC1s), which which then forms then formsC3 C3 convertaseconvertase (C4b2a). The The lectin lectin pathway pathway is initiate is initiatedd by the by binding the binding of mannose-binding of mannose-binding lectin lectinwith withmannose mannose residues residues on pathogen on pathogen surfaces, surfaces, which which activates activates mannose-associated mannose-associated serine serine proteases proteases (MASPs) to form the same C3 convertase (C4b2a). The alternative pathway is triggered directly by (MASPs) to form the same C3 convertase (C4b2a). The alternative pathway is triggered directly antigen and also through spontaneous autoactivation, leading to the formation of a similar C3 by antigen and also through spontaneous autoactivation, leading to the formation of a similar C3 convertase (C3bBb). These C3 convertases hydrolyze C3 to yield the C5 convertases (C4b2a3b and convertaseC3bBbC3b, (C3bBb).respectively), These which C3 convertasesculminates in hydrolyze the generation C3 to of yield C5b-9 the or C5 MAC convertases (membrane (C4b2a3b attack andcomplex). C3bBbC3b, respectively), which culminates in the generation of C5b-9 or MAC (membrane attack complex). The complement system’s role in innate immunity is an important first line of protectionThe complement against invading system’s pathogens. role in innate Impo immunityrtantly, isexcessive an important activation first line can of lead protec- to tionmaladaptive against invading host inflammatory pathogens. Importantly,responses with excessive life-threatening activation caneffects. lead Recent to maladaptive research host inflammatory responses with life-threatening effects. Recent research shows that shows that exuberant complement activation causes pathogenic systemic inflammatory exuberant complement activation causes pathogenic systemic inflammatory response syn- response syndrome, endothelial dysfunction, and multiorgan dysfunction [10–12]. drome, endothelial dysfunction, and multiorgan dysfunction [10–12]. 3.3. MethodologyMethodology andand LiteratureLiterature SearchSearch TheThe PubMedPubMed literature literature search search strategy strategy (initial (initial search search date 14 date August 14 August 2020 and 2020 updated and onupdated 14 April on 2021) 14 April combined 2021) free-textcombined keywords free-text COVID, keywords SARS-CoV-2, COVID, SARS-CoV-2, and complement. and Filterscomplement. for the searchFilters for were the applied, search were and theapplied, filters and included the filters humans included [species], humans English [species], [lan- guage],English and[language], journal articles and journal [article articles types]. The[article number types]. of searchThe number results totaledof search618 results items, includingtotaled 618 abstract items, only. including ClinicalTrials.gov abstract only. was ClinicalTrials.gov accessed, the search was strategy accessed, (initial the searchsearch datestrategy 14 August (initial 2020search and date updated 14 August on 14 2020 April and 2021) updated utilized on the14 April search 2021) terms utilized “COVID” the forsearch condition terms “COVID” or disease, for and condition “complement”. or disease, The and total “complement”. number of search The total results number totaled of 49.search With results the 667 totaled items 49. at hand,With the 667 cited items items at totaled hand, the 98, includingcited items 31 totaled original 98, articles, including 41 reviews,31 original 2 textbook, articles, 41 16 reviews, clinical trials, 2 textbook, and 8 websites.16 clinical trials, and 8 websites. 4.4. Complement inin SARS-CoV-1,SARS-CoV-1, MERS-CoVMERS-CoV TheThe understandingunderstanding ofof SARS-CoV-2SARS-CoV-2 hashas leveragedleveraged priorprior researchresearch inin SARSSARS causedcaused byby relatedrelated virusesviruses inin thethe beta-Coronaviridaebeta-Coronaviridae family,family, SARS-CoVSARS-CoV andand MiddleMiddle EastEast respiratoryrespiratory syndromesyndrome coronavirus (MERS-CoV) [13]. [13]. SARS-CoV SARS-CoV originated originated in in Guangdong, Guangdong, China, China, in in2002, 2002, causing causing 8422 8422 infections infections and and916 deaths, 916 deaths, with witha case a fatality case fatality rate of rate10.8% of [14]. 10.8% MERS- [14]. J. Clin. Med. 2021, 10, 2188 3 of 13 MERS-CoV originated in Saudi Arabia in 2012, causing 2468 infections and 851 deaths, with a case fatality rate of 34.4% [15]. SARS-CoV-2 emerged in December 2019 in Wuhan, China. By 17 April 2021, there were over 136.7 million confirmed cases and 3.0 million deaths, with a case fatality rate of 2.1% [16]. Gralinski and colleagues performed the first in vivo studies of SARS-CoV in C57BL/6J mice that showed complement activation as early as day 1 post-infection [11]. To determine whether this complement cascade response was protective or pathologic, they tested the impact of viral infection in C3-deficient (C3-/-) mice. C3-/- mice had equivalent viral loads as control mice, indicating that complement signaling is not necessary for SARS-CoV clearance in lung. Compared to controls, SARS-CoV-infected C3-/- mice exhibited less weight loss and respiratory dysfunction, as well as decreased inflammation as measured by neutrophils, monocytes, cytokines, and chemokines both on lung pathology as well as sera. These data suggest that SARS-CoV lung injury progression may be driven by complement activation. Jiang and
Recommended publications
  • Role of the Renin–Angiotensin–Aldosterone and Kinin–Kallikrein Systems in the Cardiovascular Complications of COVID-19 and Long COVID

    Role of the Renin–Angiotensin–Aldosterone and Kinin–Kallikrein Systems in the Cardiovascular Complications of COVID-19 and Long COVID

    International Journal of Molecular Sciences Review Role of the Renin–Angiotensin–Aldosterone and Kinin–Kallikrein Systems in the Cardiovascular Complications of COVID-19 and Long COVID Samantha L. Cooper 1,2,*, Eleanor Boyle 3, Sophie R. Jefferson 3, Calum R. A. Heslop 3 , Pirathini Mohan 3, Gearry G. J. Mohanraj 3, Hamza A. Sidow 3, Rory C. P. Tan 3, Stephen J. Hill 1,2 and Jeanette Woolard 1,2,* 1 Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, University of Nottingham, Nottingham NG7 2UH, UK; [email protected] 2 Centre of Membrane Proteins and Receptors (COMPARE), School of Life Sciences, University of Nottingham, Nottingham NG7 2UH, UK 3 School of Medicine, Queen’s Medical Centre, University of Nottingham, Nottingham NG7 2UH, UK; [email protected] (E.B.); [email protected] (S.R.J.); [email protected] (C.R.A.H.); [email protected] (P.M.); [email protected] (G.G.J.M.); [email protected] (H.A.S.); [email protected] (R.C.P.T.) * Correspondence: [email protected] (S.L.C.); [email protected] (J.W.); Tel.: +44-115-82-30080 (S.L.C.); +44-115-82-31481 (J.W.) Abstract: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is the virus responsible Citation: Cooper, S.L.; Boyle, E.; for the COVID-19 pandemic. Patients may present as asymptomatic or demonstrate mild to severe Jefferson, S.R.; Heslop, C.R.A.; and life-threatening symptoms. Although COVID-19 has a respiratory focus, there are major cardio- Mohan, P.; Mohanraj, G.G.J.; Sidow, vascular complications (CVCs) associated with infection.
  • Studies on a Complex Mechanism for the Activation of Plasminogen by Kaolin and by Chloroform: the Participation of Hageman Factor and Additional Cofactors

    Studies on a Complex Mechanism for the Activation of Plasminogen by Kaolin and by Chloroform: the Participation of Hageman Factor and Additional Cofactors

    Studies on a complex mechanism for the activation of plasminogen by kaolin and by chloroform: the participation of Hageman factor and additional cofactors Derek Ogston, … , Oscar D. Ratnoff, Charles D. Forbes J Clin Invest. 1969;48(10):1786-1801. https://doi.org/10.1172/JCI106145. Research Article As demonstrated by others, fibrinolytic activity was generated in diluted, acidified normal plasma exposed to kaolin, a process requiring Hageman factor (Factor XII). Generation was impaired by adsorbing plasma with glass or similar agents under conditions which did not deplete its content of Hageman factor or plasminogen. The defect could be repaired by addition of a noneuglobulin fraction of plasma or an agent or agents eluted from diatomaceous earth which had been exposed to normal plasma. The restorative agent, tentatively called Hageman factor-cofactor, was partially purified by chromatography and had an apparent molecular weight of approximately 165,000. It could be distinguished from plasma thromboplastin antecedent (Factor XI) and plasma kallikrein, other substrates of Hageman factor, and from the streptokinase-activated pro-activator of plasminogen. Evidence is presented that an additional component may be needed for the generation of fibrinolytic activity in mixtures containing Hageman factor, HF-cofactor, and plasminogen. The long-recognized generation of plasmin activity in chloroform-treated euglobulin fractions of plasma was found to be dependent upon the presence of Hageman factor. Whether chloroform activation of plasminogen requires Hageman factor-cofactor was not determined, but glass-adsorbed plasma, containing Hageman factor and plasminogen, did not generate appreciable fibrinolytic or caseinolytic activity. These studies emphasize the complex nature of the mechanisms which lead to the generation of plasmin in human plasma.
  • Download, Or Email Articles for Individual Use

    Download, Or Email Articles for Individual Use

    Florida State University Libraries Faculty Publications The Department of Biomedical Sciences 2010 Functional Intersection of the Kallikrein- Related Peptidases (KLKs) and Thrombostasis Axis Michael Blaber, Hyesook Yoon, Maria Juliano, Isobel Scarisbrick, and Sachiko Blaber Follow this and additional works at the FSU Digital Library. For more information, please contact [email protected] Article in press - uncorrected proof Biol. Chem., Vol. 391, pp. 311–320, April 2010 • Copyright ᮊ by Walter de Gruyter • Berlin • New York. DOI 10.1515/BC.2010.024 Review Functional intersection of the kallikrein-related peptidases (KLKs) and thrombostasis axis Michael Blaber1,*, Hyesook Yoon1, Maria A. locus (Gan et al., 2000; Harvey et al., 2000; Yousef et al., Juliano2, Isobel A. Scarisbrick3 and Sachiko I. 2000), as well as the adoption of a commonly accepted Blaber1 nomenclature (Lundwall et al., 2006), resolved these two fundamental issues. The vast body of work has associated 1 Department of Biomedical Sciences, Florida State several cancer pathologies with differential regulation or University, Tallahassee, FL 32306-4300, USA expression of individual members of the KLK family, and 2 Department of Biophysics, Escola Paulista de Medicina, has served to elevate the importance of the KLKs in serious Universidade Federal de Sao Paulo, Rua Tres de Maio 100, human disease and their diagnosis (Diamandis et al., 2000; 04044-20 Sao Paulo, Brazil Diamandis and Yousef, 2001; Yousef and Diamandis, 2001, 3 Program for Molecular Neuroscience and Departments of 2003;
  • Activation of the Plasma Kallikrein-Kinin System in Respiratory Distress Syndrome

    Activation of the Plasma Kallikrein-Kinin System in Respiratory Distress Syndrome

    003 I-3998/92/3204-043 l$03.00/0 PEDIATRIC RESEARCH Vol. 32. No. 4. 1992 Copyright O 1992 International Pediatric Research Foundation. Inc. Printed in U.S.A. Activation of the Plasma Kallikrein-Kinin System in Respiratory Distress Syndrome OLA D. SAUGSTAD, LAILA BUP, HARALD T. JOHANSEN, OLAV RPISE, AND ANSGAR 0. AASEN Department of Pediatrics and Pediatric Research [O.D.S.].Institute for Surgical Research. University of Oslo [L.B.. A.O.A.], Rikshospitalet, N-0027 Oslo 1, Department of Surgery [O.R.],Oslo City Hospital Ullev~il University Hospital, N-0407 Oslo 4. Department of Pharmacology [H. T.J.],Institute of Pharmacy, University of Oslo. N-0316 Oslo 3, Norway ABSTRAm. Components of the plasma kallikrein-kinin proteins that interact in a complicated way. When activated, the and fibrinolytic systems together with antithrombin 111 contact factors plasma prekallikrein, FXII, and factor XI are were measured the first days postpartum in 13 premature converted to serine proteases that are capable of activating the babies with severe respiratory distress syndrome (RDS). complement, fibrinolytic, coagulation, and kallikrein-kinin sys- Seven of the patients received a single dose of porcine tems (7-9). Inhibitors regulate and control the activation of the surfactant (Curosurf) as rescue treatment. Nine premature cascades. C1-inhibitor is the most important inhibitor of the babies without lung disease or any other complicating contact system (10). It exerts its regulatory role by inhibiting disease served as controls. There were no differences in activated FXII, FXII fragment, and plasma kallikrein (10). In prekallikrein values between surfactant treated and non- addition, az-macroglobulin and a,-protease inhibitor inhibit treated RDS babies during the first 4 d postpartum.
  • Assessing Plasmin Generation in Health and Disease

    Assessing Plasmin Generation in Health and Disease

    International Journal of Molecular Sciences Review Assessing Plasmin Generation in Health and Disease Adam Miszta 1,* , Dana Huskens 1, Demy Donkervoort 1, Molly J. M. Roberts 1, Alisa S. Wolberg 2 and Bas de Laat 1 1 Synapse Research Institute, 6217 KD Maastricht, The Netherlands; [email protected] (D.H.); [email protected] (D.D.); [email protected] (M.J.M.R.); [email protected] (B.d.L.) 2 Department of Pathology and Laboratory Medicine and UNC Blood Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; [email protected] * Correspondence: [email protected]; Tel.: +31-(0)-433030693 Abstract: Fibrinolysis is an important process in hemostasis responsible for dissolving the clot during wound healing. Plasmin is a central enzyme in this process via its capacity to cleave fibrin. The ki- netics of plasmin generation (PG) and inhibition during fibrinolysis have been poorly understood until the recent development of assays to quantify these metrics. The assessment of plasmin kinetics allows for the identification of fibrinolytic dysfunction and better understanding of the relationships between abnormal fibrin dissolution and disease pathogenesis. Additionally, direct measurement of the inhibition of PG by antifibrinolytic medications, such as tranexamic acid, can be a useful tool to assess the risks and effectiveness of antifibrinolytic therapy in hemorrhagic diseases. This review provides an overview of available PG assays to directly measure the kinetics of plasmin formation and inhibition in human and mouse plasmas and focuses on their applications in defining the role of plasmin in diseases, including angioedema, hemophilia, rare bleeding disorders, COVID- 19, or diet-induced obesity.
  • The Characteristic Normalization of the Severely Prolonged Aptt Following Increased Preincubation Time Is Due to Autoactivation of Factor XII

    The Characteristic Normalization of the Severely Prolonged Aptt Following Increased Preincubation Time Is Due to Autoactivation of Factor XII

    Thrombosis Research 105 (2002) 463–470 Regular Article Prekallikrein deficiency: The characteristic normalization of the severely prolonged aPTT following increased preincubation time is due to autoactivation of factor XII Lars M. Asmis*, Irmela Sulzer, Miha Furlan, Bernhard La¨mmle Central Hematology Laboratory, University of Bern, Inselspital, Bern CH 3010, Switzerland Received 8 November 2001; received in revised form 14 December 2001; accepted 28 January 2002 Accepting Editor: J. Meier Abstract Hereditary plasma prekallikrein (PK) deficiency was diagnosed in a 71-year-old man with an 8-year history of osteomyelofibrosis. PK deficiency was suspected in view of a severely prolonged activated partial thromboplastin time (aPTT) that nearly normalized following prolonged preincubation (10 min) of patient plasma with kaolin–inosithin reagent. Hereditary PK deficiency was demonstrated by very low PK values in the propositus (PK clotting activity 5%, PK amidolytic activity 5%, PK antigen 2% of normal plasma, respectively) and half normal PK values in his children. Normalization of a severely increased aPTT ( > 120 s) after prolonged preincubation with aPTT reagent occurred in plasma deficient in PK but not in plasma deficient in factor XII (FXII), high-molecular-weight kininogen (HK), factor XI (FXI), factor IX, factor VIII, Passovoy trait plasma or plasma containing lupus anticoagulant. Autoactivation of FXII in PK-deficient plasma in the presence of kaolin paralleled the normalization of aPTT. Addition of OT-2, a monoclonal antibody inhibiting activated FXII, prevented the normalization of aPTT. We conclude that the normalization of a severely prolonged aPTT upon increased preincubation time (PIT), characteristic of PK deficiency, is due to FXII autoactivation.
  • Factor XII-Driven Inflammatory Reactions with Implications for Anaphylaxis

    Factor XII-Driven Inflammatory Reactions with Implications for Anaphylaxis

    REVIEW published: 15 September 2017 doi: 10.3389/fimmu.2017.01115 Factor XII-Driven Inflammatory Reactions with Implications for Anaphylaxis Lysann Bender1, Henri Weidmann1, Stefan Rose-John 2, Thomas Renné1,3 and Andy T. Long1* 1 Institute of Clinical Chemistry and Laboratory Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, 2 Biochemical Institute, University of Kiel, Kiel, Germany, 3 Clinical Chemistry, Department of Molecular Medicine and Surgery, L1:00 Karolinska Institutet and University Hospital, Stockholm, Sweden Anaphylaxis is a life-threatening allergic reaction. It is triggered by the release of pro- inflammatory cytokines and mediators from mast cells and basophils in response to immunologic or non-immunologic mechanisms. Mediators that are released upon mast cell activation include the highly sulfated polysaccharide and inorganic polymer heparin and polyphosphate (polyP), respectively. Heparin and polyP supply a negative surface for factor XII (FXII) activation, a serine protease that drives contact system-mediated coagulation and inflammation. Activation of the FXII substrate plasma kallikrein leads Edited by: to further activation of zymogen FXII and triggers the pro-inflammatory kallikrein–kinin Vanesa Esteban, system that results in the release of the mediator bradykinin (BK). The severity of ana- Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Spain phylaxis is correlated with the intensity of contact system activation, the magnitude of Reviewed by: mast cell activation, and BK formation. The main inhibitor of the complement system, Edward Knol, C1 esterase inhibitor, potently interferes with FXII activity, indicating a meaningful cross- University Medical Center link between complement and kallikrein–kinin systems. Deficiency in a functional C1 Utrecht, Netherlands Maria M.
  • The Role of the Plasminogen Activation System in Angioedema: Novel Insights on the Pathogenesis

    The Role of the Plasminogen Activation System in Angioedema: Novel Insights on the Pathogenesis

    Journal of Clinical Medicine Review The Role of the Plasminogen Activation System in Angioedema: Novel Insights on the Pathogenesis Filomena Napolitano and Nunzia Montuori * Department of Translational Medical Sciences and Center for Basic and Clinical Immunology Research (CISI), University of Naples Federico II, 80135 Naples, Italy; fi[email protected] * Correspondence: [email protected]; Tel.: +39-0817463309 Abstract: The main physiological functions of plasmin, the active form of its proenzyme plasminogen, are blood clot fibrinolysis and restoration of normal blood flow. The plasminogen activation (PA) system includes urokinase-type plasminogen activator (uPA), tissue-type PA (tPA), and two types of plasminogen activator inhibitors (PAI-1 and PAI-2). In addition to the regulation of fibrinolysis, the PA system plays an important role in other biological processes, which include degradation of extracellular matrix such as embryogenesis, cell migration, tissue remodeling, wound healing, angiogenesis, inflammation, and immune response. Recently, the link between PA system and angioedema has been a subject of scientific debate. Angioedema is defined as localized and self- limiting edema of subcutaneous and submucosal tissues, mediated by bradykinin and mast cell mediators. Different forms of angioedema are linked to uncontrolled activation of coagulation and fibrinolysis systems. Moreover, plasmin itself can induce a potentiation of bradykinin production with consequent swelling episodes. The number of studies investigating the PA system involvement in angioedema has grown in recent years, highlighting its relevance in etiopathogenesis. In this review, we present the components and diverse functions of the PA system in physiology and its importance in angioedema pathogenesis. Citation: Napolitano, F.; Montuori, Keywords: angioedema; fibrinolysis; plasmin; uPAR; tPA N.
  • The Molecular Basis of Blood Coagulation Review

    The Molecular Basis of Blood Coagulation Review

    Cell, Vol. 53, 505-518, May 20, 1988, Copyright 0 1988 by Cell Press The Molecular Basis Review of Blood Coagulation Bruce Furie and Barbara C. Furie into the fibrin polymer. The clot, formed after tissue injury, Center for Hemostasis and Thrombosis Research is composed of activated platelets and fibrin. The clot Division of Hematology/Oncology mechanically impedes the flow of blood from the injured Departments of Medicine and Biochemistry vessel and minimizes blood loss from the wound. Once a New England Medical Center stable clot has formed, wound healing ensues. The clot is and Tufts University School of Medicine gradually dissolved by enzymes of the fibrinolytic system. Boston, Massachusetts 02111 Blood coagulation may be initiated through either the in- trinsic pathway, where all of the protein components are present in blood, or the extrinsic pathway, where the cell- Overview membrane protein tissue factor plays a critical role. Initia- tion of the intrinsic pathway of blood coagulation involves Blood coagulation is a host defense system that assists in the activation of factor XII to factor Xlla (see Figure lA), maintaining the integrity of the closed, high-pressure a reaction that is promoted by certain surfaces such as mammalian circulatory system after blood vessel injury. glass or collagen. Although kallikrein is capable of factor After initiation of clotting, the sequential activation of cer- XII activation, the particular protease involved in factor XII tain plasma proenzymes to their enzyme forms proceeds activation physiologically is unknown. The collagen that through either the intrinsic or extrinsic pathway of blood becomes exposed in the subendothelium after vessel coagulation (Figure 1A) (Davie and Fiatnoff, 1964; Mac- damage may provide the negatively charged surface re- Farlane, 1964).
  • Activation of Human Factor VII in Plasma and in Purified Systems

    Activation of Human Factor VII in Plasma and in Purified Systems

    Activation of Human Factor VII in Plasma and in Purified Systems ROLES OF ACTIVATED FACTOR IX, KALLIKREIN, AND ACTIVATED FACTOR XII URI SELIGSOHN, BJARNE OSTERUD, STEPHEN F. BROWN, JOHN H. GRIFFIN, and SAMUEL I. RAPAPORT, Department of Medicine, University of California, San Diego 92093; and San Diego Veterans Administration Hospital, San Diego, California, and Department of Immunopathologjy, Scripps Clinic and Research Foundation, La Jolla, Californiia 92093 A B S T R A C T Factor VII can be activated, to a had no additional indirect activating effect in the molecule giving shorter clotting times with tissue fac- presence of plasma. These results demonstrate that tor, by incubating plasma with kaolin or by clotting both Factor XIIa and Factor IXa directly activate human plasma. The mechanisms of activation differ. With Factor VII, whereas kallikrein, through generation of kaolin, activated Factor XII (XIIa) was the apparent Factor XIIa and Factor IXa, functions as an indirect principal activator. Thus, Factor VII was not activated activator of Factor VII. in Factor XII-deficient plasma, was partially activated in prekallikrein and high-molecular weight kininogen INTRODUCTION (HMW kininogen)-deficient plasmas, but was activated in other deficient plasmas. After clotting, activated Factor VII activity, as measured in one-stage Factor Factor IX (IXa) was the apparent principal activator. VII clotting assays (1), increases several fold when Thus, Factor VII was not activated in Factor XII-, blood is exposed to a surface such as glass or kaolin (1), HMW kininogen-, XI-, and IX-deficient plasmas, but or when blood is allowed to clot (2). Factor VII activity was activated in Factor VIII-, X-, and V-deficient also increases when plasma from women taking oral plasmas.
  • Activation of the Classical Pathway of Complement by Hageman Factor Fragment*

    Activation of the Classical Pathway of Complement by Hageman Factor Fragment*

    CORE Metadata, citation and similar papers at core.ac.uk Provided by PubMed Central ACTIVATION OF THE CLASSICAL PATHWAY OF COMPLEMENT BY HAGEMAN FACTOR FRAGMENT* BY BERHANE GHEBREHIWET, MICHAEL SILVERBERG, AND ALLEN P. KAPLAN From the Department of Medicine, Division of Allergy, Rheumatology, and Clinical Immunology, State University of New York, Stony Brook, New York 11794 There is a striking similarity between the mechanisms involved in the activation of the complement system and those of the Hageman factor-dependent pathways that lead to blood coagulation, fibrinolysis, and kinin formation Both systems require an initial contact with an activator which in turn triggers a cascade of reactions involving the sequential interactions of a series of enzymes and regulators. Furthermore, certain pro_reins seem to operate as regulators of both systems. The serum C1 inactivator (CI-INA), 1 an inhibitor of activated C1 that is absent in patients with hereditary angioedema (1), is known to inhibit the activities ofplasmin (2, 3), activated Ha_geman factor (2-5), anaphylatoxin inactivator (2), Factor XIa (6), kallikrein (2, 7),C lr, and Cls (2, 3) through the formation of stoichiometric complexes. In the absence of C 1-INA, activated Hageman factor may activate the kinin system by conversion of prekallikrein to kallikrein, which in turn cleaves bradykinin from high molecular weight kininogen. Since bradykinin is a potent mediator of enhanced vascular permeability, the pathogenesis of hereditary angioedema may involve interactions between the Hageman factor-dependent pathways and the classical pathway of complement activation. Previous evidence has suggested that C 1 activation in this disease is Hageman factor dependent (8).
  • Kallikrein Directly Interacts with and Activates Factor IX, Resulting in Thrombin Generation and Fibrin Formation Independent of Factor XI

    Kallikrein Directly Interacts with and Activates Factor IX, Resulting in Thrombin Generation and Fibrin Formation Independent of Factor XI

    Kallikrein directly interacts with and activates Factor IX, resulting in thrombin generation and fibrin formation independent of Factor XI Katherine J. Kearneya,1, Juliet Butlera,1, Olga M. Posadaa, Clare Wilsona, Samantha Heala, Majid Alia, Lewis Hardya, Josefin Ahnströmb, David Gailanic, Richard Fosterd, Emma Hethershawa, Colin Longstaffe, and Helen Philippoua,2 aLeeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, LS2 9JT Leeds, United Kingdom; bFaculty of Medicine, Department of Immunology and Inflammation, Imperial College London, Hammersmith Campus, W12 0NN London, United Kingdom; cDivision of Hematology/Oncology, The Vanderbilt Clinic, Vanderbilt University, Nashville, TN 37232; dSchool of Chemistry, University of Leeds, LS2 9JT Leeds, United Kingdom; and eDivision of Biotherapeutics, National Institute for Biological Standards and Control, Potters Bar, Hertfordshire, EN6 3QG, United Kingdom Edited by Barry S. Coller, The Rockefeller University, New York, NY, and approved December 3, 2020 (received for review July 15, 2020) Kallikrein (PKa), generated by activation of its precursor prekallikrein generated stimulates the intrinsic pathway of coagulation by ac- (PK), plays a role in the contact activation phase of coagulation and tivating FXI, which then converts FIX to FIXa, and FIXa acti- functions in the kallikrein-kinin system to generate bradykinin. vation of FX to FXa, at which point the intrinsic and extrinsic The general dogma has been that the contribution of PKa to the pathways converge. coagulation cascade is dependent on its action on FXII. Recently In addition to its role in the intrinsic pathway of coagulation, this dogma has been challenged by studies in human plasma PKa also functions in the kallikrein-kinin system by cleaving HK, showing thrombin generation due to PKa activity on FIX and also releasing the vasoactive peptide bradykinin (BK) (15).